WO2019093497A8 - Adamts5に対するアプタマー及びその使用 - Google Patents
Adamts5に対するアプタマー及びその使用 Download PDFInfo
- Publication number
- WO2019093497A8 WO2019093497A8 PCT/JP2018/041746 JP2018041746W WO2019093497A8 WO 2019093497 A8 WO2019093497 A8 WO 2019093497A8 JP 2018041746 W JP2018041746 W JP 2018041746W WO 2019093497 A8 WO2019093497 A8 WO 2019093497A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aptamer
- adamts5
- ggggccucc
- formula
- ggacyaaacc
- Prior art date
Links
- 108091023037 Aptamer Proteins 0.000 title abstract 4
- 108091005663 ADAMTS5 Proteins 0.000 abstract 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical class CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/712—Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/344—Position-specific modifications, e.g. on every purine, at the 3'-end
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201880072486.6A CN111542607A (zh) | 2017-11-09 | 2018-11-09 | 针对adamts5的适配体及其应用 |
CA3081823A CA3081823A1 (en) | 2017-11-09 | 2018-11-09 | Aptamer for adamts5 and use for aptamer for adamts5 |
KR1020207016137A KR20200079534A (ko) | 2017-11-09 | 2018-11-09 | Adamts5에 대한 앱타머, 및 adamts5에 대한 앱타머의 용도 |
US16/761,880 US11473089B2 (en) | 2017-11-09 | 2018-11-09 | Aptamer for ADAMTS5 and use for aptamer for ADAMTS5 |
JP2019552413A JPWO2019093497A1 (ja) | 2017-11-09 | 2018-11-09 | Adamts5に対するアプタマー及びその使用 |
AU2018363996A AU2018363996A1 (en) | 2017-11-09 | 2018-11-09 | Aptamer for ADAMTS5, and use for aptamer for ADAMTS5 |
EP18875651.4A EP3708666A4 (en) | 2017-11-09 | 2018-11-09 | APTAMER FOR ADAMTS5 AND USE FOR APTAMER FOR ADAMTS5 |
SG11202004154SA SG11202004154SA (en) | 2017-11-09 | 2018-11-09 | Aptamer for adamts5 and use for aptamer for adamts5 |
IL274435A IL274435B1 (en) | 2017-11-09 | 2018-11-09 | Aptamer for ADAMTS5, and use of aptamer for ADAMTS5 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017216280 | 2017-11-09 | ||
JP2017-216280 | 2017-11-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2019093497A1 WO2019093497A1 (ja) | 2019-05-16 |
WO2019093497A8 true WO2019093497A8 (ja) | 2020-07-02 |
Family
ID=66437904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2018/041746 WO2019093497A1 (ja) | 2017-11-09 | 2018-11-09 | Adamts5に対するアプタマー及びその使用 |
Country Status (10)
Country | Link |
---|---|
US (1) | US11473089B2 (ja) |
EP (1) | EP3708666A4 (ja) |
JP (2) | JPWO2019093497A1 (ja) |
KR (1) | KR20200079534A (ja) |
CN (1) | CN111542607A (ja) |
AU (1) | AU2018363996A1 (ja) |
CA (1) | CA3081823A1 (ja) |
IL (1) | IL274435B1 (ja) |
SG (1) | SG11202004154SA (ja) |
WO (1) | WO2019093497A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024054922A1 (en) * | 2022-09-07 | 2024-03-14 | Synoa Therapeutics, Llc | Methods and compositions comprising novel bispecific antibodies |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2763958B2 (ja) | 1990-06-11 | 1998-06-11 | ネクスター ファーマスーティカルズ,インコーポレイテッド | 核酸リガンド |
US5660985A (en) | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
WO1994008050A1 (en) | 1992-09-29 | 1994-04-14 | Nexagen, Inc. | Nucleic acid ligands and methods for producing the same |
JPH09502354A (ja) | 1993-09-08 | 1997-03-11 | ネクスター ファーマスーティカルズ,インコーポレイテッド | 核酸リガンドと、同リガンドを製造するための改良された方法 |
KR20080036595A (ko) | 2005-07-05 | 2008-04-28 | 가부시키가이샤 리보믹 | 면역글로불린 g에 결합하는 핵산과 그 이용법 |
TWI532842B (zh) | 2009-06-11 | 2016-05-11 | 力博美科股份有限公司 | 針對凝乳酶之適體及其用途 |
MX2012000055A (es) * | 2009-07-02 | 2012-01-27 | Glaxo Group Ltd | Polipeptidos y metodo de tratamiento. |
WO2015163458A1 (ja) * | 2014-04-24 | 2015-10-29 | 株式会社リボミック | オートタキシンに結合しオートタキシンの生理活性を阻害するアプタマー及びその利用 |
WO2016103042A1 (en) * | 2014-12-25 | 2016-06-30 | Guangzhou Ribobio Co., Ltd. | Compositions and methods for inhibiting expression of adamts-5 and adam17 |
JP2017216280A (ja) | 2016-05-30 | 2017-12-07 | 豊田合成株式会社 | Iii 族窒化物半導体発光素子とその製造方法 |
-
2018
- 2018-11-09 JP JP2019552413A patent/JPWO2019093497A1/ja active Pending
- 2018-11-09 KR KR1020207016137A patent/KR20200079534A/ko not_active Application Discontinuation
- 2018-11-09 EP EP18875651.4A patent/EP3708666A4/en active Pending
- 2018-11-09 IL IL274435A patent/IL274435B1/en unknown
- 2018-11-09 SG SG11202004154SA patent/SG11202004154SA/en unknown
- 2018-11-09 CA CA3081823A patent/CA3081823A1/en active Pending
- 2018-11-09 CN CN201880072486.6A patent/CN111542607A/zh active Pending
- 2018-11-09 AU AU2018363996A patent/AU2018363996A1/en active Pending
- 2018-11-09 WO PCT/JP2018/041746 patent/WO2019093497A1/ja unknown
- 2018-11-09 US US16/761,880 patent/US11473089B2/en active Active
-
2023
- 2023-05-01 JP JP2023075870A patent/JP2023099157A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA3081823A1 (en) | 2019-05-16 |
JPWO2019093497A1 (ja) | 2021-01-21 |
US20210246451A1 (en) | 2021-08-12 |
US11473089B2 (en) | 2022-10-18 |
EP3708666A1 (en) | 2020-09-16 |
WO2019093497A1 (ja) | 2019-05-16 |
EP3708666A4 (en) | 2021-07-21 |
IL274435A (en) | 2020-06-30 |
IL274435B1 (en) | 2024-03-01 |
JP2023099157A (ja) | 2023-07-11 |
SG11202004154SA (en) | 2020-06-29 |
KR20200079534A (ko) | 2020-07-03 |
AU2018363996A1 (en) | 2020-05-28 |
CN111542607A (zh) | 2020-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4257613A3 (en) | Bispecific checkpoint inhibitor antibodies | |
PH12017502090A1 (en) | Heterocyclic amides as kinase inhibitors | |
EP4335874A3 (en) | Anti-hla-g antibodies and use thereof | |
PH12016500676A1 (en) | Pyrimidine fgfr4 inhibitors | |
MY175896A (en) | Anti-complement factor c1q antibodies and uses thereof | |
MX2018008815A (es) | Inhibidores de tirosina quinasa de bruton. | |
ATE485359T1 (de) | Verwendung von grenzflächenaktiven, nicht- enzymatischen proteinen für die textilwäsche | |
BR112015016526A2 (pt) | misturas de corantes com dispersão rápida e alta umidade | |
EA201992147A1 (ru) | Ингибиторы тирозинкиназы брутона | |
MX2020010951A (es) | Anticuerpos anti-hla-g y utilizacion de los mismos. | |
MX2020001793A (es) | Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos. | |
CR20140128A (es) | Inhibidores de la enzima activadora de nedd 8 | |
NZ712339A (en) | Extensible fixing device | |
MX2019010643A (es) | Formas y composiciones de un inhibidor de proteina cinasa 2 activada por la proteina cinasa activada por mitogeno (mk2). | |
PH12018502233A1 (en) | ErbB INHIBITORS AND USES THEREOF | |
MX2015013365A (es) | Derivados de urea y su uso como inhibidores de proteina de union de acidos grasos (puag). | |
MX2020003507A (es) | Compuestos pirimidinicos inhibidores de (tbk)/(ikk) epsilon y usos de los mismos. | |
CL2022001452A1 (es) | Inhibidores de masp-2 y métodos de uso. | |
WO2019093497A8 (ja) | Adamts5に対するアプタマー及びその使用 | |
MY197202A (en) | A liquid formulation of anti-tnf alpha antibody | |
EA201690434A1 (ru) | Маркирующие соединения и их применение в анализах | |
MX2016009402A (es) | Premezcla de abrillantador fluorescente. | |
CL2020001705A1 (es) | Composición acuosa que comprende ácido 2-(dimetil-1h-pirazol-1-il) succínico y amoníaco. | |
AU2018203040A1 (en) | Combined fixing tool | |
MX2015013374A (es) | Derivados de urea y su uso como inhibidores de proteina de uniuon a acidos grasos (puag). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18875651 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2019552413 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 3081823 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2018363996 Country of ref document: AU Date of ref document: 20181109 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20207016137 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2018875651 Country of ref document: EP Effective date: 20200609 |